Thapa(R),Fuloria(NK),Bhat(AA),Porwal(O),An... Clin Chim Acta 2026-09-15

...ELN 2022, and treatment exposure help clarify the clinical significance of FLT3 results. A particular focus is placed on...

Zeng(Y),Hui(Y),Yan(L),Fang(QY),Li(Y),Wang(... Zhonghua Xue Ye Xue Za Zhi 2026-05-14

...ELN risk classification and major AML mutation subgroups. The primary outcome measures included overall survival (OS), r...

Mo(Q),Xie(G),Huang(K),Nie(W),Chen(H),Yang(... Front Cell Dev Biol None

...ELN risk, IL-12, IL-18, and IL-21 between incomplete remission (ICR) and CR status. These cytokines were at weakened lev...

Li(D),Du(L),Yi(G),Liang(T),Midgley(AC),Shu... J Nanobiotechnology 2026-07-10

...ELNs derived from the extremophyte Rosa roxburghii (R-ELNs) and Artemisia sphaerocephala Krasch (A-ELNs) against intesti...

Jiang(KY),Lin(HT),Song(CW),Yu(ZW),Tang(HT)... Ann Surg Oncol 2026-09-00

...ELNS) may define dissection extent. This study aims to determine optimal ELNS for accurate nodal staging and overall sur...

Xu(W),Gao(J),Wu(S),Huang(J),An(C),Jiang(C)... JCI Insight 2026-05-22

...ELN as a CAF-derived driver of metastasis and immune evasion in BCa. Targeting the ELN-TGFBR2 interaction offers a promi...

Bai(J),Liu(W),Wang(Z),Han(B),Qi(H),Sun(J) Mater Today Bio 2026-06-00

...ELNs) with polydopamine (PDA) and chelating gadolinium ions (Gd), denoted as PDA@ELNs/Gd. This platform exhibits enhance...

Qian(X),Cao(C),Liu(L) Metabolites 2026-05-21

...ELN) were used to optimize modeling conditions via Cell Counting Kit-8 (CCK-8) and enzyme-linked immunosorbent assay (EL...

Choudhary(A),Ramesh(R),Kar(R),Narasimhan(P... Indian J Hematol Blood Tran... 2026-09-00

...ELN) 2017 criteria into good (27%), intermediate (56%), and poor (17%) risk groups. Immune profiling included flow cytom...

Shahani(W),Guriro(K),Bashir(Z),Memon(AA),N... Indian J Hematol Blood Tran... 2026-09-00

...ELN (mELN) criteria. Out of 81 patients, 42 PV (51.9%) and 39 ET (48.1%) were evaluated. Higher median age was observed ...